PNC Financial Services Group Inc. raised its stake in McKesson Corporation (NYSE:MCK – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 244,414 shares of the company’s stock after buying an additional 2,158 shares during the quarter. PNC Financial Services Group Inc.’s holdings in McKesson were worth $200,490,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of MCK. GGM Financials LLC bought a new position in McKesson in the third quarter valued at approximately $25,000. State of Wyoming bought a new position in McKesson in the second quarter valued at approximately $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the third quarter valued at approximately $31,000. Vermillion & White Wealth Management Group LLC bought a new position in McKesson in the third quarter valued at approximately $33,000. Finally, Board of the Pension Protection Fund bought a new position in McKesson in the fourth quarter valued at approximately $33,000. Institutional investors own 85.07% of the company’s stock.
Insider Activity
In other news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the sale, the executive vice president directly owned 3,247 shares of the company’s stock, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.08% of the stock is currently owned by insiders.
Analyst Ratings Changes
Get Our Latest Research Report on MCK
McKesson Price Performance
Shares of MCK opened at $755.39 on Thursday. The firm has a 50-day moving average of $844.88 and a 200-day moving average of $856.50. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The company has a market cap of $90.80 billion, a PE ratio of 19.64, a price-to-earnings-growth ratio of 1.14 and a beta of 0.35.
McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. During the same quarter last year, the company posted $10.12 earnings per share. McKesson’s quarterly revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Analysts expect that McKesson Corporation will post 44.29 earnings per share for the current year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s dividend payout ratio (DPR) is presently 8.53%.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Articles
- Five stocks we like better than McKesson
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
